Literature DB >> 2451002

Acceleration of desensitization by agonist pre-treatment in the snake.

J F Fiekers1, D S Neel, R L Parsons.   

Abstract

1. The kinetics of carbachol-induced desensitization have been studied in snake twitch-muscle fibres maintained in an isotonic potassium propionate solution and voltage clamped to +50 mV. 2. Microperfusion of carbachol (162-756 microM) induces a transient outward current which peaks within a few seconds and then slowly decays towards the base line. The time course of current decay estimates the time course of desensitization onset. 3. Brief exposure (30 s) to a 'conditioning' concentration of agonist (10.8 microM) accelerates the desensitization onset produced by exposure to higher 'test' concentrations of agonist (162-756 microM). 4. The acceleration of desensitization by pre-treatment with 10.8 microM-carbachol was independent of the duration of exposure between 15 and 60 s. This observation indicated that the mechanism responsible for the alteration in desensitization kinetics by treatment with 10.8 microM-carbachol differed from that responsible for the time-dependent development of desensitization produced in the presence of higher carbachol concentrations. 5. Pre-treatment with the muscarinic agonists, methylcholine and bethanechol, did not accelerate 216 microM-carbachol-induced desensitization, suggesting that the alteration of desensitization kinetics by pre-treatment was specific for nicotinic agonists. 6. The conditioning concentrations of carbachol (5.4-10.8 microM) produced no measurable outward current in muscle fibres voltage clamped to +50 mV. Further, in patch-clamp recordings it was observed that, with these concentrations of carbachol, there was no channel activity in many successful patches voltage clamped to +50 mV and, when present, the frequency of channel activity was very low. These results demonstrated that the alteration in desensitization was not the consequence of significant amounts of either receptor activation or desensitization produced by the conditioning concentration. 7. Exposure to 10.8 microM-carbachol for periods of up to 150 s did not change the amplitude of miniature end-plate currents recorded at end-plates voltage clamped to +50 mV. These results also demonstrated that the acceleration of desensitization by pre-treatment with conditioning concentrations of agonist was not due to partial desensitization occurring during the pre-treatment period. 8. Our results are consistent with the view that there are distinct populations of agonist binding sites on the acetylcholine receptor which separately regulate desensitization and channel opening.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2451002      PMCID: PMC1192205          DOI: 10.1113/jphysiol.1987.sp016729

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  24 in total

1.  A possible involvement of cyclic AMP in the expression of desensitization of the nicotinic acetylcholine receptor. A study with forskolin and its analogs.

Authors:  E X Albuquerque; S S Deshpande; Y Aracava; M Alkondon; J W Daly
Journal:  FEBS Lett       Date:  1986-04-07       Impact factor: 4.124

2.  Nicotinic acetylcholine receptor contains multiple binding sites: evidence from binding of alpha-dendrotoxin.

Authors:  B M Conti-Tronconi; M A Raftery
Journal:  Proc Natl Acad Sci U S A       Date:  1986-09       Impact factor: 11.205

3.  Effects of proteolytic enzymes on function and structure of frog neuromuscular junctions.

Authors:  W Betz; B Sakmann
Journal:  J Physiol       Date:  1973-05       Impact factor: 5.182

4.  A comparative study of the activation of the cholinergic receptor by various agonists.

Authors:  A Trautmann
Journal:  Proc R Soc Lond B Biol Sci       Date:  1983-05-23

5.  An analysis of the dose-response relationship at voltage-clamped frog neuromuscular junctions.

Authors:  V E Dionne; J H Steinbach; C F Stevens
Journal:  J Physiol       Date:  1978-08       Impact factor: 5.182

6.  The nicotinic acetylcholine receptor: its structure, multiple binding sites, and cation transport properties.

Authors:  M A Raftery; B M Conti-Tronconi; S M Dunn; R D Crawford; D Middlemas
Journal:  Fundam Appl Toxicol       Date:  1984-04

Review 7.  The nicotinic cholinergic receptor: correlation of molecular structure with functional properties.

Authors:  B M Conti-Tronconi; M A Raftery
Journal:  Annu Rev Biochem       Date:  1982       Impact factor: 23.643

8.  Desensitization at the frog neuromuscular junction: a biphasic process.

Authors:  A Feltz; A Trautmann
Journal:  J Physiol       Date:  1982-01       Impact factor: 5.182

9.  Dependence of acetylcholine desensitization on the membrane potential of frog muscle fibre and on the ionic changes in the medium.

Authors:  L G Magazanik; F Vyskocil
Journal:  J Physiol       Date:  1970-10       Impact factor: 5.182

10.  Activation and desensitization of Torpedo acetylcholine receptor: evidence for separate binding sites.

Authors:  S M Dunn; M A Raftery
Journal:  Proc Natl Acad Sci U S A       Date:  1982-11       Impact factor: 11.205

View more
  4 in total

1.  A molecular scheme for the reaction between acetylcholine and nicotinic channels.

Authors:  C Franke; H Parnas; G Hovav; J Dudel
Journal:  Biophys J       Date:  1993-02       Impact factor: 4.033

2.  Mechanism of staurosporine-induced decrease in acetylcholine receptor recovery from desensitization.

Authors:  J C Hardwick; R L Parsons
Journal:  Br J Pharmacol       Date:  1993-03       Impact factor: 8.739

3.  Necessity of divalent cations for recovery from carbachol-induced nicotinic acetylcholine receptor inactivation at snake twitch fibre endplates.

Authors:  J C Hardwick; R L Parsons
Journal:  Br J Pharmacol       Date:  1993-10       Impact factor: 8.739

4.  Staurosporine inhibits the extent of acetylcholine receptor recovery from carbachol-induced desensitization in snake twitch fibres.

Authors:  J C Hardwick; L M Coniglio; R L Parsons
Journal:  Br J Pharmacol       Date:  1991-12       Impact factor: 8.739

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.